Skip to main content
Erschienen in: Diabetologia 1/2012

01.01.2012 | Article

Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines

verfasst von: H.-S. Moon, J. P. Chamberland, C. S. Mantzoros

Erschienen in: Diabetologia | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

It has been suggested that amylin amplifies leptin’s effects and affects energy homeostasis synergistically with leptin in animals and humans. However, no previous study has reported on amylin and leptin signalling in hypothalamic, muscle and liver cells.

Methods

Leptin and amylin signalling studies were performed in vitro in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines.

Results

Treatment of mouse GT1-7 and C2C12 cells with leptin or amylin increased signal transducer and activator of transcription 3 (STAT3) phosphorylation in a dose- and time-dependent manner. In mouse AML12 cells, leptin and amylin produced a biphasic response of STAT3 activity. Importantly, all leptin and amylin signalling pathways were saturable at leptin and amylin concentrations of ∼100 and ∼50 to 100 ng/ml, respectively. Leptin and amylin in combination activated STAT3, AMP-activated protein kinase (AMPK), extracellular signal-regulated kinase (ERK) 1/2 and Akt signalling pathways in an additive manner, effects that were abolished under endoplasmic reticulum (ER) stress. Leptin, but not amylin, increased IRS-1 phosphorylation in GT1-7 hypothalamic, but not in C2C12 muscle and AML12 liver cell lines.

Conclusions/interpretation

Our data suggest that leptin and amylin have overlapping and additive, but not synergistic, effects in the activation of intracellular signalling pathways. ER stress may induce leptin and amylin resistance in hypothalamic, muscle and liver cell lines. These novel insights into the mode of action of leptin and amylin suggest that these hormones may play an additive role in regulating energy homeostasis in humans.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Badman MK, Flier JS (2005) The gut and energy balance: visceral allies in the obesity wars. Science 307:1909–1914PubMedCrossRef Badman MK, Flier JS (2005) The gut and energy balance: visceral allies in the obesity wars. Science 307:1909–1914PubMedCrossRef
2.
Zurück zum Zitat Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS (2010) Leptin in human physiology and therapeutics. Front Neuroendocrinol 31:377–393PubMedCrossRef Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS (2010) Leptin in human physiology and therapeutics. Front Neuroendocrinol 31:377–393PubMedCrossRef
3.
Zurück zum Zitat Fiorenza CG, Chou SH, Mantzoros CS (2011) Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol 7:137–150PubMedCrossRef Fiorenza CG, Chou SH, Mantzoros CS (2011) Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol 7:137–150PubMedCrossRef
4.
Zurück zum Zitat Moon HS, Matarese G, Brennan AM et al (2011) Efficacy of metreleptin in obese type II diabetics: cellular and molecular pathways underlying leptin tolerance. Diabetes 60:1647–1656PubMedCrossRef Moon HS, Matarese G, Brennan AM et al (2011) Efficacy of metreleptin in obese type II diabetics: cellular and molecular pathways underlying leptin tolerance. Diabetes 60:1647–1656PubMedCrossRef
5.
Zurück zum Zitat Moon HS, Chamberland JP, Diakopoulos KN et al (2010) Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues; in vitro and ex vivo studies in humans. Diabetes Care 34:132–138PubMedCrossRef Moon HS, Chamberland JP, Diakopoulos KN et al (2010) Leptin and amylin act in an additive manner to activate overlapping signaling pathways in peripheral tissues; in vitro and ex vivo studies in humans. Diabetes Care 34:132–138PubMedCrossRef
6.
Zurück zum Zitat Matarese G, Moschos S, Mantzoros CS (2005) Leptin in immunology. J Immunol 174:3137–3142PubMed Matarese G, Moschos S, Mantzoros CS (2005) Leptin in immunology. J Immunol 174:3137–3142PubMed
7.
Zurück zum Zitat Pelleymounter MA, Cullen MJ, Baker MB et al (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540–543PubMedCrossRef Pelleymounter MA, Cullen MJ, Baker MB et al (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269:540–543PubMedCrossRef
8.
Zurück zum Zitat Kim YB, Uotani S, Pierroz DD, Flier JS, Kahn BB (2000) In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141:2328–2339PubMedCrossRef Kim YB, Uotani S, Pierroz DD, Flier JS, Kahn BB (2000) In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141:2328–2339PubMedCrossRef
9.
Zurück zum Zitat Roth JD, Maier H, Chen S, Roland BL (2009) Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications. Arch Neurol 66:306–310PubMedCrossRef Roth JD, Maier H, Chen S, Roland BL (2009) Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications. Arch Neurol 66:306–310PubMedCrossRef
10.
Zurück zum Zitat Ravussin E, Smith SR, Mitchell JA et al (2009) Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring) 17:1736–1743CrossRef Ravussin E, Smith SR, Mitchell JA et al (2009) Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring) 17:1736–1743CrossRef
11.
Zurück zum Zitat Roth JD, Roland BL, Cole RL et al (2008) Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 105:7257–7262PubMedCrossRef Roth JD, Roland BL, Cole RL et al (2008) Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci USA 105:7257–7262PubMedCrossRef
12.
Zurück zum Zitat Trevaskis JL, Coffey T, Cole R et al (2008) Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. Endocrinology 149:5679–5687PubMedCrossRef Trevaskis JL, Coffey T, Cole R et al (2008) Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. Endocrinology 149:5679–5687PubMedCrossRef
13.
Zurück zum Zitat Hwang JJ, Chan JL, Ntali G, Malkova D, Mantzoros CS (2008) Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide— Interventional studies in humans. Diabetes Care 31:945–951PubMedCrossRef Hwang JJ, Chan JL, Ntali G, Malkova D, Mantzoros CS (2008) Leptin does not directly regulate the pancreatic hormones amylin and pancreatic polypeptide— Interventional studies in humans. Diabetes Care 31:945–951PubMedCrossRef
14.
Zurück zum Zitat Ozcan L, Ergin AS, Lu A et al (2009) Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 9:35–51PubMedCrossRef Ozcan L, Ergin AS, Lu A et al (2009) Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab 9:35–51PubMedCrossRef
15.
Zurück zum Zitat Hagiwara S, Iwasaka H, Shingu C et al (2009) Heat shock protein 72 protects insulin-secreting beta cells from lipopolysaccharide-induced endoplasmic reticulum stress. Int J Hyperthermia 25:626–633PubMedCrossRef Hagiwara S, Iwasaka H, Shingu C et al (2009) Heat shock protein 72 protects insulin-secreting beta cells from lipopolysaccharide-induced endoplasmic reticulum stress. Int J Hyperthermia 25:626–633PubMedCrossRef
16.
Zurück zum Zitat Moon HS, Chung CS, Lee HG, Kim TG, Choi YJ, Cho CS (2007) Inhibitory effect of (–)-epigallocatechin-3-gallate on lipid accumulation of 3 T3-L1 cells. Obesity (Silver Spring) 15:2571–2582CrossRef Moon HS, Chung CS, Lee HG, Kim TG, Choi YJ, Cho CS (2007) Inhibitory effect of (–)-epigallocatechin-3-gallate on lipid accumulation of 3 T3-L1 cells. Obesity (Silver Spring) 15:2571–2582CrossRef
17.
Zurück zum Zitat Maroni P, Bendinelli P, Piccoletti R (2005) Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell Biol Int 29:542–550PubMedCrossRef Maroni P, Bendinelli P, Piccoletti R (2005) Intracellular signal transduction pathways induced by leptin in C2C12 cells. Cell Biol Int 29:542–550PubMedCrossRef
18.
Zurück zum Zitat Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661–671PubMed Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661–671PubMed
19.
Zurück zum Zitat Ahima RS, Saper CB, Flier JS, Elmquist JK (2000) Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21:263–307PubMedCrossRef Ahima RS, Saper CB, Flier JS, Elmquist JK (2000) Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21:263–307PubMedCrossRef
20.
Zurück zum Zitat Bates SH, Myers MG (2003) The role of leptin receptor signalling in feeding and neuroendocrine function. Trends Endocrinol Metab 14:447–452PubMedCrossRef Bates SH, Myers MG (2003) The role of leptin receptor signalling in feeding and neuroendocrine function. Trends Endocrinol Metab 14:447–452PubMedCrossRef
21.
Zurück zum Zitat Turek VF, Trevaskis JL, Levin BE et al (2010) Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 151:143–152PubMedCrossRef Turek VF, Trevaskis JL, Levin BE et al (2010) Mechanisms of amylin/leptin synergy in rodent models. Endocrinology 151:143–152PubMedCrossRef
22.
Zurück zum Zitat Hardie DG, Carling D, Carlson M (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821–855PubMedCrossRef Hardie DG, Carling D, Carlson M (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67:821–855PubMedCrossRef
23.
Zurück zum Zitat Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA (1999) Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 24:22–25PubMedCrossRef Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA (1999) Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 24:22–25PubMedCrossRef
24.
Zurück zum Zitat Holmes BF, Kurth-Kraczek EJ, Winder WW (1999) Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87:1990–1995PubMed Holmes BF, Kurth-Kraczek EJ, Winder WW (1999) Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J Appl Physiol 87:1990–1995PubMed
25.
Zurück zum Zitat Bjorbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305–331PubMedCrossRef Bjorbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305–331PubMedCrossRef
26.
Zurück zum Zitat Suzuki A, Okamoto S, Lee S, Saito K, Shiuchi T, Minokoshi Y (2007) Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol 27:4317–4327PubMedCrossRef Suzuki A, Okamoto S, Lee S, Saito K, Shiuchi T, Minokoshi Y (2007) Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol 27:4317–4327PubMedCrossRef
27.
Zurück zum Zitat Rahmouni K, Sigmund CD, Haynes WG, Mark AL (2009) Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 58:536–542PubMedCrossRef Rahmouni K, Sigmund CD, Haynes WG, Mark AL (2009) Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin. Diabetes 58:536–542PubMedCrossRef
28.
Zurück zum Zitat Huang XF, Chen JZ (2009) Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev 10:610–616PubMedCrossRef Huang XF, Chen JZ (2009) Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev 10:610–616PubMedCrossRef
29.
Zurück zum Zitat Lang T, Ikejima K, Yoshikawa M et al (2004) Leptin facilitates proliferation of hepatic stellate cells through up-regulation of platelet-derived growth factor receptor. Biochem Biophys Res Commun 323:1091–1095PubMedCrossRef Lang T, Ikejima K, Yoshikawa M et al (2004) Leptin facilitates proliferation of hepatic stellate cells through up-regulation of platelet-derived growth factor receptor. Biochem Biophys Res Commun 323:1091–1095PubMedCrossRef
30.
Zurück zum Zitat Misztal-Dethloff B, Stepien H, Komorowski J (2004) Effect of leptin on proliferative activity and vascular endothelial growth factor (VEGF) secretion from cultured endothelial cells HECa10 in vitro. Endocr Regul 38:161–166PubMed Misztal-Dethloff B, Stepien H, Komorowski J (2004) Effect of leptin on proliferative activity and vascular endothelial growth factor (VEGF) secretion from cultured endothelial cells HECa10 in vitro. Endocr Regul 38:161–166PubMed
31.
Zurück zum Zitat Cohen B, Novick D, Rubinstein M (1996) Modulation of insulin activities by leptin. Science 274:1185–1188PubMedCrossRef Cohen B, Novick D, Rubinstein M (1996) Modulation of insulin activities by leptin. Science 274:1185–1188PubMedCrossRef
32.
Zurück zum Zitat Mosthaf L, Kellerer M, Mühlhöfer A, Mushack J, Seffer E, Häring HU (1996) Insulin leads to a parallel translocation of PI-3-kinase and protein kinase C zeta. Exp Clin Endocrinol Diabetes 104:19–24PubMedCrossRef Mosthaf L, Kellerer M, Mühlhöfer A, Mushack J, Seffer E, Häring HU (1996) Insulin leads to a parallel translocation of PI-3-kinase and protein kinase C zeta. Exp Clin Endocrinol Diabetes 104:19–24PubMedCrossRef
33.
Zurück zum Zitat Niswender KD, Morton GJ, Steams WH, Rhodes CJ, Myers MG Jr, Schwartz MW (2001) Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413:794–795PubMedCrossRef Niswender KD, Morton GJ, Steams WH, Rhodes CJ, Myers MG Jr, Schwartz MW (2001) Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413:794–795PubMedCrossRef
34.
Zurück zum Zitat Anisimov SV, Christophersen NS, Correia AS et al (2010) Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells. Cell Mol Biol Lett 16:79–88PubMedCrossRef Anisimov SV, Christophersen NS, Correia AS et al (2010) Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells. Cell Mol Biol Lett 16:79–88PubMedCrossRef
35.
Zurück zum Zitat Magariños MP, Sánchez-Margalet V, Kotler M, Calvo JC, Varone CL (2007) Leptin promotes cell proliferation and survival of trophoblastic cells. Biol Reprod 76:203–210PubMedCrossRef Magariños MP, Sánchez-Margalet V, Kotler M, Calvo JC, Varone CL (2007) Leptin promotes cell proliferation and survival of trophoblastic cells. Biol Reprod 76:203–210PubMedCrossRef
36.
Zurück zum Zitat Jiang L, Li Z, Rui L (2008) Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways. J Biol Chem 283:28066–28073PubMedCrossRef Jiang L, Li Z, Rui L (2008) Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways. J Biol Chem 283:28066–28073PubMedCrossRef
37.
Zurück zum Zitat Cornish J, Callon KE, Bava U et al (2006) Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo. Am J Physiol Endocrinol Metab 292:E117–E122PubMedCrossRef Cornish J, Callon KE, Bava U et al (2006) Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo. Am J Physiol Endocrinol Metab 292:E117–E122PubMedCrossRef
38.
39.
Zurück zum Zitat Chan JL, Mantzoros CS (2005) Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 366:74–85PubMedCrossRef Chan JL, Mantzoros CS (2005) Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 366:74–85PubMedCrossRef
40.
Zurück zum Zitat Lee JH, Chan JL, Sourlas E, Raptopoulos V, Mantzoros CS (2006) Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. J Clin Endocrinol Metab 91:2605–2611PubMedCrossRef Lee JH, Chan JL, Sourlas E, Raptopoulos V, Mantzoros CS (2006) Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. J Clin Endocrinol Metab 91:2605–2611PubMedCrossRef
41.
Zurück zum Zitat Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152:93–100PubMed Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152:93–100PubMed
42.
Zurück zum Zitat Ziemke F, Mantzoros CS (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91:258S–261SPubMedCrossRef Ziemke F, Mantzoros CS (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91:258S–261SPubMedCrossRef
Metadaten
Titel
Amylin and leptin activate overlapping signalling pathways in an additive manner in mouse GT1-7 hypothalamic, C2C12 muscle and AML12 liver cell lines
verfasst von
H.-S. Moon
J. P. Chamberland
C. S. Mantzoros
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 1/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2332-0

Weitere Artikel der Ausgabe 1/2012

Diabetologia 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.